Page 1 of 3

Diabetes Research Paper

Continues for 2 more pages »
Read full document

Diabetes Research Paper

  • By
  • November 2009
  • 767 Words
  • 30 Views
Page 1 of 3
New Medications & Methods of Insulin Delivery
{text:bookmark-start} {text:bookmark-end} DIABETES RESEARCH PAPER Pharmacology 8 a.m.
New Medications & Methods of Insulin Delivery
APA 1
Kelsie Marie Hargrays
St. Cloud Technical College
Abstract
{text:bookmark-start} {text:bookmark-end} The research I did was on new medications and methods of insulin delivery. I researched a few new medications that help treat type 1 & 2 diabetes. I also researched about new methods of delivery and found many different methods however, some of them have not yet made it on the market yet. Another thing I found while conducting my research is that these two topics I have advantages and disadvantages as well which is just another thing that I have included in my research paper. New Medications & Methods of Insulin Delivery

Many people around the world of all ages suffer with diabetes every day. The ultimate goal is to cure diabetes and as information technology rapidly improves, diabetes gadgetry is riding its wake. New Diabetes Medication

Currently, there are six types of pills that can help people manage type 1 & 2 diabetes: sulfonylureas, meglitinides, metformin, thiazolidinediones, alpha-glycosidase inhibitors, and DPP-4 inhibitors. There has also been talk about four pharmaceutical classes on the horizon for treating high blood glucose: sodium-glucose co transporter inhibitors, glucokinase activators, glucagon receptor antagonists, and sirtuins. Cycloset was also proved not to increase the risk of heart attack and stroke. Not only that but, Cycloset has also shown to blunt after-meal glucose spikes throughout the day, leading to lower average glucose levels. Another plus to this medications is the fact that it can be used alone or in combination with other diabetes medications to help improve blood glucose control. These are just some of the advantages to this new medication. In a press release, Brian Schrader, cochairman of S2 Therapeutics, a...

Rate this document

What do you think about the quality of this document?

Share this document

Let your classmates know about this document and more at Studymode.com